Shree Ganesh Bio-Tech (India) Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 190.29 million compared to INR 78.42 million a year ago. Revenue was INR 190.31 million compared to INR 78.42 million a year ago. Net income was INR 9.5 million compared to INR 3.66 million a year ago. Basic earnings per share from continuing operations was INR 0.024 compared to INR 0.009 a year ago. Diluted earnings per share from continuing operations was INR 0.024 compared to INR 0.009 a year ago.
For the nine months, sales was INR 525.05 million compared to INR 79.56 million a year ago. Revenue was INR 525.56 million compared to INR 79.56 million a year ago. Net income was INR 24.56 million compared to INR 2.87 million a year ago. Basic earnings per share from continuing operations was INR 0.0615 compared to INR 0.007 a year ago. Diluted earnings per share from continuing operations was INR 0.0615 compared to INR 0.007 a year ago.